Journal of Cancer Research and Therapeutics Close
 

Figure 3: Workflow for chimeric antigen receptor-T cell therapy. It starts with isolating T cells from the blood withdrawn from a donor and engineering it in vitro to express chimeric antigen receptors on the surface of the cells. These clones are selected and re-infused back into the patients

Figure 3: Workflow for chimeric antigen receptor-T cell therapy. It starts with isolating T cells from the blood withdrawn from a donor and engineering it <i>in vitro</i> to express chimeric antigen receptors on the surface of the cells. These clones are selected and re-infused back into the patients